34 results on '"Zhou, Jinxue"'
Search Results
2. Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST
3. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy
4. The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy
5. Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
6. A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma
7. Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
8. Predictive Factors of Treatment Outcomes After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in the Hepatocaval Confluence: A Propensity Score Matching Analysis
9. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases
10. MTHFD2 reprograms macrophage polarization by inhibiting PTEN
11. Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance.
12. Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?
13. Laparoscopic liver resection versus radiofrequency ablation for caudate lobe solitary hepatocellular carcinoma: A propensity score matching study
14. The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy.
15. Comparative efficacy and safety of systemic therapy for advanced hepatocellular carcinoma: a systematic review and network meta-analysis
16. Liver round-ligament retraction method in LPD: A technical note
17. Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance
18. Application of modified Blumgart "Figure-of-Eight" pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy:A technical note
19. Genetic Analysis of Pediatric Pancreatoblastoma: A Case Report
20. Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
21. Gallbladder cancer: current and future treatment options
22. Local-regional therapy combined with toripalimab and lenvatinib in patients with advanced biliary tract cancer
23. Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
24. Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
25. The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations
26. Lenvatinib plus toripalimab with local-regional therapy in patients with advanced biliary tract cancer: a retrospective study
27. Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
28. Application of modified Blumgart "Figure-of-Eight" pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy:A technical note
29. Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study.
30. Editorial: Impact of emerging treatment modalities on stromal cells in the tumour microenvironment.
31. Induction of MTHFD2 in Macrophages Inhibits Reactive Oxygen Species-mediated NF-κB Activation and Protects against Inflammatory Responses.
32. Tyrosine phosphatase PTPN11/ SHP2 in solid tumors - bull's eye for targeted therapy?
33. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
34. Local-regional therapy combined with toripalimab and lenvatinib in patients with advanced biliary tract cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.